(617) 206-1055

Official logo of Stem Cell Therapy Experts featuring clean, clinical design with holistic symbolism

Hematopoietic Stem Cells: Risks to Know

Hematopoietic Stem Cells: Powerful for Blood, Limited for Regeneration

Conditions We Treat

  • Osteoarthritis

  • Rheumatoid Arthritis

  • Psoriatic Arthritis

  • Neuropathy

  • Chronic Pain

  • Long COVID

  • Multiple Sclerosis

  • COPD

  • Autoimmune Conditions

These are just a few of the conditions we address with regenerative therapy.

See the Full List of Conditions We Treat

Conditions Treated

Hematopoietic Stem Cells: Powerful for Blood, Limited for Regeneration

The term hematopoietic comes from the Greek words hema (blood) and poiesis (to make). Hematopoietic stem cells (HSCs) are the stem cells in your bone marrow responsible for producing all the blood cells in your body. That includes red blood cells that carry oxygen, white blood cells that fight infections, and platelets that help your blood clot. In short, hematopoietic stem cells are crucial to keeping your blood and immune systems functioning.

Because of this, HSCs are commonly used in treatments for serious blood-related conditions such as leukemia, lymphoma, and aplastic anemia. These cells are often transplanted after chemotherapy or radiation to rebuild the patient’s immune system—a practice known as bone marrow transplantation.

However, outside of blood-related illnesses, HSCs are not an appropriate option for most regenerative treatments.

Why SCTE Does Not Use Hematopoietic Stem Cells

At Stem Cell Therapy Experts (SCTE), we are often asked why we don’t use hematopoietic stem cells in our therapies. The reason is simple: they are not regenerative in the ways our patients need.

“Hematopoietic stem cells are not the ideal candidates to treat joint issues or autoimmune conditions… they can be tumoric and trigger immune responses if not matched.” — Dr. Yi Song

While HSCs are powerful for rebuilding blood and immune cells, they do not regenerate cartilage, nerves, or organs. For conditions like osteoarthritis, autoimmune diseases, or neurodegeneration, hematopoietic stem cells offer limited, if any, benefit. Even worse, they may introduce risks that outweigh potential gains.

Risks of HSC Use in Non-Hematologic Conditions

  • Tumor Risk: Hematopoietic stem cells, particularly if not screened or matched properly, can form tumors in inappropriate environments.
  • Immune Response: HSCs carry surface markers that can trigger rejection unless the donor and recipient are genetically matched.
  • Autologous Contamination Risk: When using a patient’s own fat or bone marrow (autologous cells), trace amounts of hematopoietic cells may remain, introducing inflammation or side effects.

These risks are why SCTE does not use HSCs, even in autologous stem cell procedures. Our goal is safe, effective, and targeted therapy—not generalized or outdated approaches.

Our Safer Alternative: Umbilical Cord Mesenchymal Stem Cells (MSCs)

Instead of hematopoietic cells, SCTE relies exclusively on lab-expanded mesenchymal stem cells derived from the umbilical cord. These stem cells are known for their ability to regulate the immune system, reduce inflammation, and stimulate regeneration of musculoskeletal, neurological, and connective tissues.

Why We Choose Umbilical Cord MSCs:

  • No Immune Rejection: MSCs are immune-privileged and do not require matching.
  • Non-Tumorigenic: When expanded and screened properly, they do not form tumors.
  • High Regenerative Potential: Especially effective for joint pain, autoimmune diseases, chronic inflammation, and age-related conditions.
  • Ethically Collected: Harvested from donated umbilical cords with full donor screening and consent.

Clinical Scenarios Where MSCs Excel

Some of the most common conditions treated with MSCs at SCTE include:
  • Joint Degeneration: Osteoarthritis of the knees, hips, or spine
  • Autoimmune Conditions: Lupus, rheumatoid arthritis, multiple sclerosis, and more
  • Neurological Disorders: Parkinson’s, Alzheimer’s, and stroke recovery
  • Anti-Aging & Inflammation: Fatigue, hormonal imbalance, and chronic pain syndromes
Diagram showing hematopoietic stem cell differentiating into red blood cells, white blood cells, and platelets on a blue background.
In all of these areas, hematopoietic stem cells offer no proven advantage—and may present unnecessary complications.

Evidence-Based Medicine Drives Our Approach

We base our protocols on decades of clinical experience and a growing body of peer-reviewed literature. Studies consistently support the safety and efficacy of mesenchymal stem cells for a range of degenerative and inflammatory conditions.

Scientific References

Talk to One Of Our Stem Cell Experts

Curious about how cell count and viability affect your treatment results? Schedule a one-on-one consultation with our clinical team to review your health goals, get transparent cell data, and receive a personalized plan—rooted in science and backed by decades of healing wisdom.

GET STARTED